AYTU BIOPHARMA, INC short interest in 2022
In 2022, AYTU BIOPHARMA, INC's disclosed short interest ran from 6.15% of shares outstanding on 14 Jan 2022 to 5.57% on 30 Dec 2022, a change of -0.58 percentage points. The year's high was 6.19% on 15 Mar 2022 and its low 2.43% on 30 Sep 2022, averaging 4.26% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.11 days on 15 Mar 2022. Full history: AYTU BIOPHARMA, INC.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 6.15% (14 Jan 2022)
- End of year
- 5.57% (30 Dec 2022)
- Change
- -0.58 pp
- High
- 6.19% (15 Mar 2022)
- Low
- 2.43% (30 Sep 2022)
- Average
- 4.26%
- Highest days to cover
- 11.11 (15 Mar 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 6.15% | 8.42 | |
| 31 Jan 2022 | 5.61% | 6.98 | |
| 15 Feb 2022 | 6.05% | 9.37 | 10-Q filed, results (8-K) |
| 28 Feb 2022 | 6.07% | 10.37 | |
| 15 Mar 2022 | 6.19% | 11.11 | |
| 31 Mar 2022 | 5.48% | 9.95 | |
| 14 Apr 2022 | 5.15% | 5.11 | |
| 29 Apr 2022 | 5.54% | 1.00 | |
| 13 May 2022 | 3.60% | 3.27 | |
| 31 May 2022 | 3.05% | 4.80 | 10-Q filed, results (8-K) |
| 15 Jun 2022 | 3.42% | 3.57 | |
| 30 Jun 2022 | 3.41% | 2.07 | |
| 15 Jul 2022 | 3.00% | 1.15 | |
| 29 Jul 2022 | 2.97% | 3.76 | |
| 15 Aug 2022 | 3.87% | 1.00 | |
| 31 Aug 2022 | 3.00% | 1.00 | |
| 15 Sep 2022 | 2.75% | 1.19 | |
| 30 Sep 2022 | 2.43% | 1.21 | 10-K filed, results (8-K) |
| 14 Oct 2022 | 2.86% | 1.52 | |
| 31 Oct 2022 | 2.85% | 3.92 | |
| 15 Nov 2022 | 3.88% | 2.53 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 4.84% | 2.06 | |
| 15 Dec 2022 | 4.54% | 3.50 | |
| 30 Dec 2022 | 5.57% | 2.81 |
See also: AYTU BIOPHARMA, INC's full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.